These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 29116020)

  • 21. Impact of timing and dose of mesenchymal stromal cell therapy in a preclinical model of acute myocardial infarction.
    Richardson JD; Bertaso AG; Psaltis PJ; Frost L; Carbone A; Paton S; Nelson AJ; Wong DT; Worthley MI; Gronthos S; Zannettino AC; Worthley SG
    J Card Fail; 2013 May; 19(5):342-53. PubMed ID: 23663817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intramyocardial injection of allogenic bone marrow-derived mesenchymal stem cells without immunosuppression preserves cardiac function in a porcine model of myocardial infarction.
    Makkar RR; Price MJ; Lill M; Frantzen M; Takizawa K; Kleisli T; Zheng J; Kar S; McClelan R; Miyamota T; Bick-Forrester J; Fishbein MC; Shah PK; Forrester JS; Sharifi B; Chen PS; Qayyum M
    J Cardiovasc Pharmacol Ther; 2005 Dec; 10(4):225-33. PubMed ID: 16382259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mesenchymal stem cell injection ameliorates the inducibility of ventricular arrhythmias after myocardial infarction in rats.
    Wang D; Zhang F; Shen W; Chen M; Yang B; Zhang Y; Cao K
    Int J Cardiol; 2011 Nov; 152(3):314-20. PubMed ID: 20674997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Macrophage subpopulations are essential for infarct repair with and without stem cell therapy.
    Ben-Mordechai T; Holbova R; Landa-Rouben N; Harel-Adar T; Feinberg MS; Abd Elrahman I; Blum G; Epstein FH; Silman Z; Cohen S; Leor J
    J Am Coll Cardiol; 2013 Nov; 62(20):1890-901. PubMed ID: 23973704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intramyocardial injections of human mesenchymal stem cells following acute myocardial infarction modulate scar formation and improve left ventricular function.
    Otto Beitnes J; Oie E; Shahdadfar A; Karlsen T; Müller RM; Aakhus S; Reinholt FP; Brinchmann JE
    Cell Transplant; 2012; 21(8):1697-709. PubMed ID: 22410280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intracoronary infusion of allogeneic mesenchymal precursor cells directly after experimental acute myocardial infarction reduces infarct size, abrogates adverse remodeling, and improves cardiac function.
    Houtgraaf JH; de Jong R; Kazemi K; de Groot D; van der Spoel TI; Arslan F; Hoefer I; Pasterkamp G; Itescu S; Zijlstra F; Geleijnse ML; Serruys PW; Duckers HJ
    Circ Res; 2013 Jul; 113(2):153-66. PubMed ID: 23658436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mesenchymal stem cell therapy: A promising cell-based therapy for treatment of myocardial infarction.
    Shafei AE; Ali MA; Ghanem HG; Shehata AI; Abdelgawad AA; Handal HR; Talaat KA; Ashaal AE; El-Shal AS
    J Gene Med; 2017 Dec; 19(12):. PubMed ID: 29044850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Iron oxide nanoparticle-mediated development of cellular gap junction crosstalk to improve mesenchymal stem cells' therapeutic efficacy for myocardial infarction.
    Han J; Kim B; Shin JY; Ryu S; Noh M; Woo J; Park JS; Lee Y; Lee N; Hyeon T; Choi D; Kim BS
    ACS Nano; 2015 Mar; 9(3):2805-19. PubMed ID: 25688594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravenous mesenchymal stem cell therapy early after reperfused acute myocardial infarction improves left ventricular function and alters electrophysiologic properties.
    Price MJ; Chou CC; Frantzen M; Miyamoto T; Kar S; Lee S; Shah PK; Martin BJ; Lill M; Forrester JS; Chen PS; Makkar RR
    Int J Cardiol; 2006 Aug; 111(2):231-9. PubMed ID: 16246440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single vs. double intracoronary injection of mesenchymal stromal cell after acute myocardial infarction: the study protocol from a randomized clinical trial: BOOSTER-TAHA7 trial.
    Attar A; Nouri F; Yazdanshenas A; Hessami K; Vosough M; Abdi-Ardekani A; Izadpanah P; Ramzi M; Kojouri J; Pouladfar G; Monabati A
    Trials; 2022 Apr; 23(1):293. PubMed ID: 35413932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mesenchymal Stem Cells and Mononuclear Cells From Cord Blood: Cotransplantation Provides a Better Effect in Treating Myocardial Infarction.
    Chen G; Yue A; Yu H; Ruan Z; Yin Y; Wang R; Ren Y; Zhu L
    Stem Cells Transl Med; 2016 Mar; 5(3):350-7. PubMed ID: 26798061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravenous Followed by X-ray Fused with MRI-Guided Transendocardial Mesenchymal Stem Cell Injection Improves Contractility Reserve in a Swine Model of Myocardial Infarction.
    Schmuck EG; Koch JM; Hacker TA; Hatt CR; Tomkowiak MT; Vigen KK; Hendren N; Leitzke C; Zhao YQ; Li Z; Centanni JM; Hei DJ; Schwahn D; Kim J; Hematti P; Raval AN
    J Cardiovasc Transl Res; 2015 Oct; 8(7):438-48. PubMed ID: 26374144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transplantation of mesenchymal stem cells carrying the human receptor activity-modifying protein 1 gene improves cardiac function and inhibits neointimal proliferation in the carotid angioplasty and myocardial infarction rabbit model.
    Shi B; Long X; Zhao R; Liu Z; Wang D; Xu G
    Exp Biol Med (Maywood); 2014 Mar; 239(3):356-65. PubMed ID: 24477823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-133 overexpression promotes the therapeutic efficacy of mesenchymal stem cells on acute myocardial infarction.
    Chen Y; Zhao Y; Chen W; Xie L; Zhao ZA; Yang J; Chen Y; Lei W; Shen Z
    Stem Cell Res Ther; 2017 Nov; 8(1):268. PubMed ID: 29178928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MSCs transfected with hepatocyte growth factor or vascular endothelial growth factor improve cardiac function in the infarcted porcine heart by increasing angiogenesis and reducing fibrosis.
    Lu F; Zhao X; Wu J; Cui Y; Mao Y; Chen K; Yuan Y; Gong D; Xu Z; Huang S
    Int J Cardiol; 2013 Sep; 167(6):2524-32. PubMed ID: 22981278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: rationale and design of the evaluation of MCC-135 for left ventricular salvage in acute MI (EVOLVE) study.
    Jang IK; Pettigrew V; Picard MH; Kowey PR; Demmel V; Zile MR; Tatsuno J; Wackers FJ; Hibberd M
    J Thromb Thrombolysis; 2005 Dec; 20(3):147-53. PubMed ID: 16261287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Mesenchymal stem cells implantation increases the myofibroblasts congregating in infarct region in a rat model of myocardial infarction].
    Du YY; Yao R; Pu S; Zhao XY; Liu GH; Zhao LS; Chen QH; Li L
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Dec; 40(12):1045-50. PubMed ID: 23363722
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Photoluminescent Mesoporous Silicon Nanoparticles with siCCR2 Improve the Effects of Mesenchymal Stromal Cell Transplantation after Acute Myocardial Infarction.
    Lu W; Xie Z; Tang Y; Bai L; Yao Y; Fu C; Ma G
    Theranostics; 2015; 5(10):1068-82. PubMed ID: 26199646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimal temporal delivery of bone marrow mesenchymal stem cells in rats with myocardial infarction.
    Hu X; Wang J; Chen J; Luo R; He A; Xie X; Li J
    Eur J Cardiothorac Surg; 2007 Mar; 31(3):438-43. PubMed ID: 17239611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. C-Kit Positive Cardiac Stem Cells and Bone Marrow-Derived Mesenchymal Stem Cells Synergistically Enhance Angiogenesis and Improve Cardiac Function After Myocardial Infarction in a Paracrine Manner.
    Bao L; Meng Q; Li Y; Deng S; Yu Z; Liu Z; Zhang L; Fan H
    J Card Fail; 2017 May; 23(5):403-415. PubMed ID: 28284757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.